Pancreatic Cancer Research

ErratumNat Commun2019

Publisher Correction: The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer.

Journal
Nat Commun
Published
15 November 2019
Citations
11
Type
Erratum
License
cc by
Full text
Open access, reuse-licensed (cc by)

These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Its licensed text is not loaded here yet, so most questions will be declined.

Try